Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Wearable glucose monitor may supercharge lifestyle change in prediabetes

NCT ID NCT06841796

Prevention Sponsor: Young Men's Christian Association of the Blue Water Area Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 18, 2026 · Last updated Aug 19, 2026 · Updated 1 time

Summary

This trial tests whether adding a real-time continuous glucose monitor (CGM) to a YMCA healthy lifestyle program helps adults with prediabetes improve their glucose levels, diet, and physical activity. Participants attend health coaching sessions and YMCA classes, with some wearing a CGM that shows their glucose data in real time for 24 weeks, while others wear a blinded monitor. The study compares changes in time spent in a healthy glucose range, dietary scores, and activity levels between the two groups.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Real-time continuous glucose monitor (CGM) device
What this could lead to
If it works, this could point toward a practical, community-based way to help people with prediabetes improve their glucose control and daily habits.
What could go wrong
This is a small, early-stage trial, so results may not apply broadly. Wearing a CGM could be inconvenient, and the device's accuracy and user engagement may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 84 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ● Adults 18 years or older AND * A diagnosis of prediabetes as defined by: * Fasting glucose 100-125 mg/dl OR * A1c 5.7-6.4% Exclusion Criteria: * Pregnancy * Previous CGM use * Lack of smart phone/smart device * Use of steroids * Active cancer treatment * Active chronic infection requiring long term use of antibiotics * Terminal illness * Dementia, mental impairment * Non English speaking

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Prediabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

prediabetes syndrome type 2 diabetes mellitus prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Prediabetes

Contacts and locations

Locations

  • YMCA of the Blue Water Area

    Port Huron, Michigan, 48060, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.